Equifax (EFX) Stock Forecast, Price Target & Predictions
EFX Stock Forecast
Equifax stock forecast is as follows: an average price target of $316.40 (represents a 21.10% upside from EFX’s last price of $261.27) and a rating consensus of 'Buy', based on 18 wall street analysts offering a 1-year stock forecast.
EFX Price Target
EFX Analyst Ratings
Buy
Equifax Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Dec 16, 2024 | Andrew Grobler | BNP Paribas | $305.00 | $260.55 | 17.06% | 16.74% |
Oct 11, 2024 | Arthur Truslove | Citigroup | $331.00 | $285.20 | 16.06% | 26.69% |
Sep 19, 2024 | Andrew Grobler | BNP Paribas | $310.00 | $297.57 | 4.18% | 18.65% |
Sep 13, 2024 | Manav Patnaik | Barclays | $380.00 | $297.77 | 27.62% | 45.44% |
Sep 12, 2024 | Toni Kaplan | New Street | $271.00 | $297.99 | -9.06% | 3.72% |
Aug 28, 2024 | Kyle Peterson | Needham | $350.00 | $305.13 | 14.71% | 33.96% |
Aug 12, 2024 | Jason Haas | Wells Fargo | $340.00 | $283.59 | 19.89% | 30.13% |
Jul 19, 2024 | Kyle Peterson | Needham | $320.00 | $265.89 | 20.35% | 22.48% |
Jul 19, 2024 | Shlomo Rosenbaum | Stifel Nicolaus | $305.00 | $264.19 | 15.45% | 16.74% |
Jul 19, 2024 | Owen Lau | Oppenheimer | $300.00 | $260.30 | 15.25% | 14.82% |
Jul 18, 2024 | George Tong | Goldman Sachs | $277.00 | $264.19 | 4.85% | 6.02% |
Jul 18, 2024 | David Togut | Evercore ISI | $305.00 | $272.15 | 12.07% | 16.74% |
Apr 19, 2024 | Owen Lau | Oppenheimer | $272.00 | $217.51 | 25.05% | 4.11% |
Apr 19, 2024 | Shlomo Rosenbaum | Stifel Nicolaus | $265.00 | $217.51 | 21.83% | 1.43% |
Apr 19, 2024 | Jeffrey Meuler | Robert W. Baird | $260.00 | $217.51 | 19.53% | -0.49% |
Apr 18, 2024 | Toni Kaplan | Morgan Stanley | $240.00 | $217.51 | 10.34% | -8.14% |
Apr 09, 2024 | Shlomo Rosenbaum | Stifel Nicolaus | $295.00 | $262.74 | 12.28% | 12.91% |
Feb 13, 2024 | David Togut | Evercore ISI | $310.00 | $247.94 | 25.03% | 18.65% |
Dec 07, 2023 | Faiza Alwy | Deutsche Bank | $267.00 | $230.38 | 15.90% | 2.19% |
Apr 21, 2023 | Ashish Sabadra | RBC Capital | $205.00 | $202.29 | 1.34% | -21.54% |
Feb 06, 2023 | Truist Financial | $260.00 | $222.56 | 16.82% | -0.49% | |
Jan 13, 2023 | Wells Fargo | $210.00 | $217.56 | -3.47% | -19.62% | |
Jan 04, 2023 | Morgan Stanley | $197.00 | $205.76 | -4.26% | -24.60% | |
Dec 16, 2022 | Stifel Stifel | Stifel Nicolaus | $222.00 | $192.63 | 15.25% | -15.03% |
Nov 18, 2022 | J.P. Morgan | $219.00 | $201.85 | 8.50% | -16.18% | |
Nov 15, 2022 | Simon Clinch | Atlantic Equities | $230.00 | $207.10 | 11.06% | -11.97% |
Nov 14, 2022 | Needham | $230.00 | $193.99 | 18.56% | -11.97% | |
Sep 27, 2022 | Morgan Stanley | $212.00 | $172.07 | 23.21% | -18.86% | |
Jul 27, 2022 | Barclays | $230.00 | $193.99 | 18.56% | -11.97% | |
Jul 22, 2022 | Deutsche Bank | $221.00 | $201.22 | 9.83% | -15.41% | |
Jul 22, 2022 | Andrew Jeffrey | Truist Financial | $230.00 | $200.56 | 14.68% | -11.97% |
Jul 22, 2022 | Morgan Stanley | $230.00 | $200.56 | 14.68% | -11.97% | |
Jul 21, 2022 | Credit Suisse | $245.00 | $200.52 | 22.18% | -6.23% | |
Jul 01, 2022 | Stifel Nicolaus | $223.00 | $183.14 | 21.76% | -14.65% | |
Jun 28, 2022 | Toni Kaplan | Morgan Stanley | $227.00 | $184.94 | 22.74% | -13.12% |
Apr 29, 2022 | David Togut | Evercore ISI | $200.00 | $203.52 | -1.73% | -23.45% |
Apr 22, 2022 | Barclays | $250.00 | $206.53 | 21.05% | -4.31% | |
Apr 22, 2022 | Credit Suisse | $250.00 | $206.44 | 21.10% | -4.31% | |
Apr 22, 2022 | Deutsche Bank | $225.00 | $202.95 | 10.86% | -13.88% | |
Apr 21, 2022 | George Tong | Goldman Sachs | $221.00 | $202.95 | 8.89% | -15.41% |
Apr 21, 2022 | RBC Capital | $244.00 | $221.41 | 10.20% | -6.61% | |
Apr 21, 2022 | Kyle Peterson | Needham | $275.00 | $202.95 | 35.50% | 5.26% |
Apr 21, 2022 | Toni Kaplan | Morgan Stanley | $250.00 | $202.95 | 23.18% | -4.31% |
Apr 20, 2022 | Jeffrey Meuler | Robert W. Baird | $281.00 | $221.41 | 26.91% | 7.55% |
Apr 18, 2022 | Faiza Alwy | Deutsche Bank | $265.00 | $214.14 | 23.75% | 1.43% |
Mar 27, 2022 | Manav Patnaik | Barclays | $300.00 | $235.46 | 27.41% | 14.82% |
Jan 20, 2022 | Georgios Mihalos | Cowen & Co. | $295.00 | $228.23 | 29.26% | 12.91% |
Nov 22, 2021 | George Gregory | BNP Paribas | $290.00 | $280.26 | 3.48% | 11.00% |
Nov 11, 2021 | Hamzah Mazari | Jefferies | $320.00 | $274.74 | 16.47% | 22.48% |
Oct 22, 2021 | David Coleman | Argus Research | $285.00 | $267.42 | 6.57% | 9.08% |
Jul 22, 2021 | George Tong | Goldman Sachs | $267.00 | $248.56 | 7.42% | 2.19% |
Apr 22, 2021 | Kevin Mcveigh | Credit Suisse | $270.00 | $220.02 | 22.72% | 3.34% |
Equifax Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 1 | 2 | 18 |
Avg Price Target | $305.00 | $318.00 | $302.00 |
Last Closing Price | $261.27 | $261.27 | $261.27 |
Upside/Downside | 16.74% | 21.71% | 15.59% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Dec 16, 2024 | Exane BNP Paribas | Neutral | Outperform | Upgrade |
Oct 18, 2024 | Wells Fargo | Buy | Buy | Hold |
Oct 11, 2024 | Citigroup | Buy | Buy | Hold |
Oct 08, 2024 | Oppenheimer | Outperform | Outperform | Hold |
Oct 01, 2024 | UBS | Buy | Initialise | |
Sep 19, 2024 | Exane BNP Paribas | Underperform | Neutral | Upgrade |
Sep 13, 2024 | Barclays | Overweight | Overweight | Hold |
Sep 12, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Aug 28, 2024 | Needham | Buy | Buy | Hold |
Aug 12, 2024 | Wells Fargo | Buy | Overweight | Initialise |
Jul 24, 2024 | Citigroup | Buy | Buy | Hold |
Jul 19, 2024 | Needham | Buy | Buy | Hold |
Jul 19, 2024 | Oppenheimer | Outperform | Outperform | Hold |
Jul 18, 2024 | Goldman Sachs | Neutral | Neutral | Hold |
Jul 18, 2024 | Evercore ISI | Outperform | Outperform | Hold |
Jul 09, 2024 | Wolfe Research | Buy | Buy | Hold |
Jul 08, 2024 | Wolfe Research | Outperform | Initialise | |
Jul 05, 2024 | Bank of America Securities | Buy | Buy | Hold |
Apr 19, 2024 | Oppenheimer | Outperform | Outperform | Hold |
Apr 15, 2024 | Citigroup | Buy | Buy | Hold |
Apr 09, 2024 | Oppenheimer | Buy | Buy | Hold |
Apr 09, 2024 | Needham | Underperform | Underperform | Hold |
Feb 29, 2024 | Oppenheimer | Underperform | Underperform | Hold |
Feb 13, 2024 | Evercore ISI | Buy | Outperform | Upgrade |
Feb 09, 2024 | Wells Fargo | Buy | Buy | Hold |
Jan 08, 2024 | Bank of America Securities | Buy | Upgrade | |
Jan 04, 2024 | Needham | Buy | Buy | Hold |
Dec 29, 2023 | Goldman Sachs | Neutral | Neutral | Hold |
Dec 18, 2023 | Jefferies | Buy | Upgrade | |
Dec 15, 2023 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
Nov 28, 2023 | CFRA | Buy | Upgrade | |
Jul 21, 2023 | Credit Suisse | Outperform | Outperform | Hold |
Apr 21, 2023 | Deutsche Bank | Hold | Hold | Hold |
Apr 21, 2023 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
Jan 13, 2023 | Wells Fargo | Equal-Weight | Equal-Weight | Hold |
Jan 10, 2023 | Goldman Sachs | Neutral | Neutral | Hold |
Jan 06, 2023 | Exane BNP Paribas | Underperform | Initialise | |
Jan 04, 2023 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Dec 02, 2022 | Barclays | Overweight | Overweight | Hold |
Nov 15, 2022 | Atlantic Equities | Neutral | Overweight | Upgrade |
Nov 14, 2022 | Needham | Buy | Buy | Hold |
Oct 20, 2022 | RBC Capital | Sector Perform | Downgrade | |
Sep 27, 2022 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
Sep 22, 2022 | Atlantic Equities | Neutral | Neutral | Hold |
Jul 27, 2022 | Barclays | Overweight | Overweight | Hold |
Jul 22, 2022 | Deutsche Bank | Hold | Hold | Hold |
Jul 22, 2022 | Morgan Stanley | Overweight | Overweight | Hold |
Jul 21, 2022 | Credit Suisse | Outperform | Outperform | Hold |
Jun 28, 2022 | Morgan Stanley | Overweight | Overweight | Hold |
Apr 29, 2022 | Evercore ISI | Buy | Downgrade | |
Apr 29, 2022 | Goldman Sachs | Hold | Hold | Hold |
Mar 27, 2022 | Barclays | Overweight | Overweight | Hold |
Equifax Financial Forecast
Equifax Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.32B | $1.32B | $1.30B | $1.20B | $1.24B | $1.32B | $1.36B | $1.25B | $1.22B | $1.23B | $1.21B | $1.12B | $1.07B | $982.80M | $957.90M | $905.80M | $875.70M |
Avg Forecast | $1.73B | $1.73B | $1.73B | $1.66B | $1.60B | $1.59B | $1.58B | $1.52B | $1.44B | $1.44B | $1.43B | $1.40B | $1.31B | $1.33B | $1.33B | $1.28B | $1.18B | $1.22B | $1.32B | $1.33B | $1.25B | $1.18B | $1.16B | $1.12B | $1.08B | $1.00B | $922.55M | $911.70M | $896.44M | $873.13M |
High Forecast | $1.77B | $1.77B | $1.77B | $1.69B | $1.64B | $1.63B | $1.62B | $1.57B | $1.45B | $1.45B | $1.43B | $1.40B | $1.33B | $1.36B | $1.35B | $1.31B | $1.21B | $1.25B | $1.36B | $1.37B | $1.29B | $1.22B | $1.20B | $1.16B | $1.12B | $1.04B | $952.01M | $940.82M | $925.07M | $901.02M |
Low Forecast | $1.67B | $1.68B | $1.68B | $1.61B | $1.55B | $1.55B | $1.53B | $1.46B | $1.42B | $1.44B | $1.42B | $1.40B | $1.29B | $1.29B | $1.28B | $1.24B | $1.15B | $1.18B | $1.28B | $1.29B | $1.21B | $1.14B | $1.12B | $1.09B | $1.05B | $972.54M | $893.26M | $882.75M | $867.98M | $845.41M |
# Analysts | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 13 | 14 | 9 | 7 | 11 | 14 | 7 | 13 | 7 | 6 | 6 | 9 | 6 | 7 | 12 | 7 | 7 | 10 | 10 | 10 | 10 | 9 | 9 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.99% | 0.99% | 1.02% | 1.01% | 1.02% | 1.00% | 1.02% | 1.00% | 1.03% | 1.06% | 1.08% | 1.03% | 1.06% | 1.07% | 1.05% | 1.01% | 1.00% |
Forecast
Equifax EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 13 | 14 | 9 | 7 | 11 | 14 | 7 | 13 | 7 | 6 | 6 | 9 | 6 | 7 | 12 | 7 | 7 | 10 | 10 | 10 | 10 | 9 | 9 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $713.10M | $404.90M | $362.00M | $340.40M | $409.70M | $448.30M | $482.80M | $310.50M | $417.70M | $430.90M | $421.10M | $249.40M | $440.10M | $256.90M | $273.60M | $140.20M | $208.80M |
Avg Forecast | $431.17M | $431.35M | $431.35M | $413.50M | $400.27M | $398.09M | $394.36M | $378.92M | $360.18M | $360.37M | $355.74M | $561.18M | $327.62M | $331.56M | $330.73M | $510.17M | $335.89M | $302.60M | $327.90M | $463.79M | $311.02M | $294.41M | $289.28M | $307.00M | $269.73M | $250.09M | $229.71M | $250.27M | $223.21M | $217.40M |
High Forecast | $440.86M | $441.05M | $441.05M | $422.80M | $409.27M | $407.05M | $403.22M | $391.31M | $362.68M | $360.86M | $355.85M | $673.42M | $332.63M | $339.01M | $338.17M | $612.20M | $403.07M | $312.27M | $338.37M | $556.55M | $320.95M | $303.81M | $298.52M | $368.39M | $278.34M | $258.08M | $237.04M | $300.32M | $230.33M | $224.35M |
Low Forecast | $418.05M | $418.22M | $418.23M | $400.92M | $388.09M | $385.98M | $382.36M | $364.07M | $355.18M | $359.89M | $355.63M | $448.95M | $322.62M | $321.47M | $320.67M | $408.13M | $268.71M | $293.00M | $317.49M | $371.03M | $301.15M | $285.06M | $280.10M | $245.60M | $261.16M | $242.15M | $222.41M | $200.22M | $216.12M | $210.50M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.15% | 1.22% | 0.71% | 1.01% | 1.35% | 1.37% | 1.04% | 1.00% | 1.42% | 1.49% | 1.37% | 0.92% | 1.76% | 1.12% | 1.09% | 0.63% | 0.96% |
Forecast
Equifax Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 13 | 14 | 9 | 7 | 11 | 14 | 7 | 13 | 7 | 6 | 6 | 9 | 6 | 7 | 12 | 7 | 7 | 10 | 10 | 10 | 10 | 9 | 9 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $217.10M | $138.30M | $112.40M | $108.20M | $165.70M | $200.60M | $221.80M | $123.00M | $205.40M | $215.10M | $201.60M | $87.40M | $224.20M | $95.90M | $112.60M | $9.20M | $81.10M |
Avg Forecast | $342.19M | $327.18M | $328.20M | $289.76M | $310.66M | $286.48M | $280.20M | $237.10M | $263.94M | $231.10M | $220.38M | $258.35M | $218.24M | $222.40M | $209.80M | $234.86M | $132.08M | $203.60M | $253.81M | $213.51M | $226.78M | $216.44M | $214.64M | $146.97M | $229.01M | $200.10M | $162.48M | $103.00M | $186.97M | $181.37M |
High Forecast | $352.19M | $336.74M | $337.80M | $298.23M | $319.74M | $294.86M | $288.39M | $277.85M | $272.69M | $233.10M | $221.71M | $310.01M | $225.77M | $228.90M | $215.93M | $281.83M | $158.50M | $212.05M | $264.34M | $256.21M | $231.80M | $225.42M | $223.55M | $176.37M | $238.52M | $208.41M | $169.22M | $123.60M | $194.73M | $188.90M |
Low Forecast | $328.65M | $314.24M | $315.22M | $278.30M | $298.37M | $275.15M | $269.11M | $204.99M | $258.93M | $229.11M | $219.05M | $206.68M | $208.21M | $213.60M | $201.50M | $187.89M | $105.67M | $195.20M | $243.33M | $170.81M | $221.76M | $207.50M | $205.78M | $117.58M | $219.56M | $191.84M | $155.77M | $82.40M | $179.25M | $173.89M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.98% | 0.66% | 0.48% | 0.82% | 0.81% | 0.79% | 1.04% | 0.54% | 0.95% | 1.00% | 1.37% | 0.38% | 1.12% | 0.59% | 1.09% | 0.05% | 0.45% |
Forecast
Equifax SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 13 | 14 | 9 | 7 | 11 | 14 | 7 | 13 | 7 | 6 | 6 | 9 | 6 | 7 | 12 | 7 | 7 | 10 | 10 | 10 | 10 | 9 | 9 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $333.10M | $343.10M | $366.10M | $340.40M | $318.00M | $330.20M | $340.30M | $343.10M | $344.20M | $328.40M | $308.80M | $366.60M | $330.00M | $309.90M | $316.00M | $389.00M | $295.50M |
Avg Forecast | $580.23M | $580.47M | $580.47M | $556.45M | $538.64M | $535.72M | $530.69M | $509.92M | $484.70M | $484.95M | $478.72M | $396.37M | $440.88M | $446.18M | $445.07M | $360.34M | $371.15M | $408.21M | $442.34M | $327.58M | $419.57M | $397.16M | $390.24M | $225.13M | $363.86M | $337.38M | $309.87M | $289.05M | $301.10M | $293.28M |
High Forecast | $593.27M | $593.52M | $593.52M | $568.96M | $550.75M | $547.76M | $542.62M | $526.58M | $488.06M | $485.60M | $478.87M | $475.64M | $447.62M | $456.21M | $455.08M | $432.40M | $445.39M | $421.25M | $456.47M | $393.09M | $432.96M | $409.84M | $402.70M | $270.15M | $375.48M | $348.15M | $319.77M | $346.87M | $310.72M | $302.64M |
Low Forecast | $562.57M | $562.80M | $562.81M | $539.51M | $522.25M | $519.41M | $514.54M | $489.92M | $477.97M | $484.30M | $478.57M | $317.10M | $434.15M | $432.60M | $431.52M | $288.27M | $296.92M | $395.25M | $428.30M | $262.06M | $406.24M | $384.55M | $377.85M | $180.10M | $352.31M | $326.66M | $300.03M | $231.24M | $291.54M | $283.96M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.75% | 0.77% | 1.02% | 0.92% | 0.78% | 0.75% | 1.04% | 0.82% | 0.87% | 0.84% | 1.37% | 1.01% | 0.98% | 1.00% | 1.09% | 1.29% | 1.01% |
Forecast
Equifax EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 6 | 6 | 12 | 11 | 10 | 9 | 8 | 13 | 14 | 9 | 7 | 11 | 14 | 7 | 13 | 7 | 6 | 6 | 9 | 6 | 7 | 12 | 7 | 7 | 10 | 10 | 10 | 10 | 9 | 9 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.77 | $1.13 | $0.92 | $0.88 | $1.35 | $1.64 | $1.82 | $1.01 | $1.68 | $1.77 | $1.66 | $0.61 | $1.84 | $0.79 | $0.93 | $0.08 | $0.67 |
Avg Forecast | $2.73 | $2.61 | $2.62 | $2.31 | $2.48 | $2.29 | $2.24 | $1.89 | $2.11 | $1.85 | $1.76 | $1.44 | $1.74 | $1.78 | $1.68 | $1.37 | $1.49 | $1.63 | $2.03 | $2.15 | $1.81 | $1.73 | $1.71 | $1.52 | $1.83 | $1.60 | $1.30 | $1.29 | $1.49 | $1.45 |
High Forecast | $2.81 | $2.69 | $2.70 | $2.38 | $2.55 | $2.36 | $2.30 | $2.22 | $2.18 | $1.86 | $1.77 | $1.51 | $1.80 | $1.83 | $1.72 | $1.40 | $1.53 | $1.69 | $2.11 | $2.24 | $1.85 | $1.80 | $1.79 | $1.59 | $1.91 | $1.66 | $1.35 | $1.34 | $1.56 | $1.51 |
Low Forecast | $2.62 | $2.51 | $2.52 | $2.22 | $2.38 | $2.20 | $2.15 | $1.64 | $2.07 | $1.83 | $1.75 | $1.38 | $1.66 | $1.71 | $1.61 | $1.33 | $1.43 | $1.56 | $1.94 | $2.06 | $1.77 | $1.66 | $1.64 | $1.46 | $1.75 | $1.53 | $1.24 | $1.24 | $1.43 | $1.39 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 0.67% | 0.67% | 0.59% | 0.83% | 0.81% | 0.85% | 0.56% | 0.97% | 1.03% | 1.09% | 0.33% | 1.15% | 0.61% | 0.72% | 0.05% | 0.46% |
Forecast
Equifax Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
FC | Franklin Covey | $36.87 | $77.50 | 110.20% | Buy |
RGP | Resources Connection | $8.12 | $13.00 | 60.10% | Buy |
FCN | FTI Consulting | $194.09 | $275.00 | 41.69% | Hold |
ICFI | ICF | $117.59 | $155.00 | 31.81% | Buy |
BAH | Booz Allen Hamilton | $129.70 | $168.83 | 30.17% | Buy |
EFX | Equifax | $261.27 | $316.40 | 21.10% | Buy |
TRU | TransUnion | $95.53 | $115.67 | 21.08% | Buy |
EXPO | Exponent | $90.45 | $104.00 | 14.98% | Hold |
HURN | Huron Consulting Group | $122.24 | $140.00 | 14.53% | Buy |
VRSK | Verisk Analytics | $278.55 | $297.50 | 6.80% | Buy |
CRAI | CRA | $188.73 | $194.00 | 2.79% |